C Schleger1, N Krebsfaenger, A Kalkuhl
1Boehringer Ingelheim Pharma KG, D-Biberach.
Early in vitro toxicological screening using cell cultures, including primary human hepatocytes and the embryonic stem cell test (EST), offers a faster, more cost-effective, and ethically sound alternative to animal studies for drug development.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: